MUC16 and pancreatic neoplasm: Here, we analyzed nine tumor markers (CA19‐9, AFP, PSA, CEA, CA125, CYFRA, CA15‐3, SCC antigen, and NCC‐ST439) in 119 patients with pancreatic cancer and 49 with hepatocellular carcinoma, alongside 590 healthy controls.